USP26 Promotes Non-Small Cell Lung Cancer Progression via Deubiquitination and Stabilization of Gαs.

Authors

Lifei Meng, Shuhan Xie, Kaimin Li, Xiaochao Zhao, Wentao Hu, Mingqiang Kang

Published in

Molecular carcinogenesis. Oct 13, 2026. Epub Oct 13, 2026.

Abstract

Non-small cell lung cancer (NSCLC) remains the leading cause of cancer-related mortality worldwide. Ubiquitin-specific protease 26 (USP26) has been implicated in tumor progression, but its functional role and molecular mechanism in NSCLC remain poorly understood. USP26 was significantly upregulated in NSCLC tissues and cell lines, correlating with poor prognosis. Functionally, USP26 promoted cell proliferation and colony formation while inhibiting apoptosis. Mechanistically, USP26 directly interacted with and deubiquitinated Gαs, stabilizing it to activate the cAMP/PKA signaling pathway. USP26 also suppressed autophagic flux and ER-phagy, and its pro-tumor effects were abrogated by the autophagy inhibitor 3-MA. Our findings demonstrate that USP26 functions as an oncogenic driver in NSCLC by stabilizing Gαs and suppressing autophagy, highlighting its potential as a prognostic biomarker and therapeutic target.

PMID:
42867290
Bibliographic data and abstract were imported from PubMed on 14 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.